REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

Cited by (999)

Items 401–500 of 999

1. Psychedelics, OCD and related disorders: A systematic review
   Marianna Graziosi, Julia Sarah Rohde, Praachi Tiwari, Jedidiah Siev, David B. Yaden · 2024 · Journal of Obsessive-Compulsive and Related Disorders
2. Psilocybin in pharmacotherapy of obsessive-compulsive disorder
   Maja Owe-Larsson, Katarzyna Kamińska, Barbara Buchalska, Dagmara Maria Mirowska-Guzel, Agnieszka Cudnoch‐Jędrzejewska · 2024 · Pharmacological Reports
3. The environmental model of mindfulness
   James Meaden · 2024 · Frontiers in Social Psychology
4. Nature heals: An informational entropy account of self-organization and change in field psychotherapy
   Pietro Sarasso, Wolfgang Tschacher, Félix Schoeller, Gianni Francesetti, Jan Roubal, Michela Gecele, Katiuscia Sacco, Irene Ronga · 2024 · Physics of Life Reviews
5. A continuum hypothesis of psychotomimetic rapid antidepressants
   Joost Haarsma, Catherine J. Harmer, Sandra Tamm · 2021 · Brain and Neuroscience Advances
6. Theories of consciousness and psychiatric disorders – A comparative analysis
   Riccardo Stefanelli · 2023 · Neuroscience & Biobehavioral Reviews
7. Psychedelics and critical theory
   Julien Tempone-Wiltshire, Tra-ill Dowie · 2023 · Journal of Psychedelic Studies
8. From Altered States to Metaphysics: The Epistemic Status of Psychedelic-induced Metaphysical Beliefs
   Paweł Gładziejewski · 2023 · Review of Philosophy and Psychology
9. Meditation and Complexity: a Systematic Review
   Daniel Andrew Atad, Pedro A. M. Mediano, Fernando E. Rosas, Aviva Berkovich‐Ohana · 2023
10. Meditation induces shifts in neural oscillations, brain complexity, and critical dynamics: novel insights from MEG
    Annalisa Pascarella, Philipp Thölke, David Meunier A, Jordan O’Byrne, Tarek Lajnef, Antonino Raffone, Roberto Guidotti, Vittorio Pizzella, Laura Marzetti, Karim Jerbi · 2025 · Neuroscience of Consciousness
11. AIT Foundations of Structured Experience
    Giulio Ruffini, Edmundo Lopez-Sola · 2022 · Journal of Artificial Intelligence and Consciousness
12. A predictive coding approach to psychedelic virtual-induced hallucinations and creative cognition in aging
    Giulia Magni, Cosimo Tuena, Giuseppe Riva · 2023 · Frontiers in Human Neuroscience
13. Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers
    Juliana Marino Maia, Bruna Stefane Alves de Oliveira, Luiz G.S. Branco, Renato Nery Soriano · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
14. Comforting delusions? How to evaluate the plausibility of mystical-type insights in psychedelic experiences
    Jussi Jylkkä · 2024 · Philosophical Psychology
15. Fire Kasina advanced meditation produces experiences comparable to psychedelic and near-death experiences: A pilot study
    Marjorie Hines Woollacott, Justin Riddle, Niffe Hermansson, Matthew D. Sacchet, Daniel M. Ingram · 2024 · EXPLORE
16. The ketamine chameleon: history, pharmacology, and the contested value of experience
    Danny Diep, Sara de la Salle, Julien Thibault Lévesque, Michael Lifshitz, Nicolas Garel, Kyle T. Greenway · 2025 · Expert Review of Clinical Pharmacology
17. Knowing and being known: Psychedelic–assisted psychotherapy and the sense of authenticity
    Lawrence G. Fischman · 2022 · Frontiers in Psychiatry
18. Aesthetic chills mitigate maladaptive cognition in depression
    Félix Schoeller, Abhinandan Jain, Vladimir Adrien, Pattie Maes, Nicco Reggente · 2024 · BMC Psychiatry
19. Bridging the gap: (a)typical psychedelic and near-death experience insights
    Pauline Fritz, Nicolas Lejeune, Paolo Cardone, Olivia Gosseries, Charlotte Martial · 2024 · Current Opinion in Behavioral Sciences
20. Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa
    Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire · 2021 · OBM Neurobiology
21. Harnessing the Spatial Foundation of Mind in Breaking Vicious Cycles in Anxiety, Insomnia, and Depression: The Future of Virtual Reality Therapy Applications
    Ravinder Jerath, Connor Beveridge · 2021 · Frontiers in Psychiatry
22. Hybrid Cognitive-Affective Strategies for AI Safety
    Nadisha-Marie Aliman · 2020 · Utrecht University Repository (Utrecht University)
23. The Nonclassic Psychedelic Ibogaine Disrupts Cognitive Maps
    Victorita E. Ivan, David P. Tomàs‐Cuesta, Ingrid M. Esteves, Davor Curic, Majid H. Mohajerani, Bruce L. McNaughton, J. Davidsen, Aaron J. Gruber · 2023 · Biological Psychiatry Global Open Science
24. Probing the functional magnetic resonance imaging response to psilocybin in functional neurological disorder (PsiFUND): study protocol
    Matthew Butler, Catherine Bird, Carolina Maggio, Amy Durden, Nadav Liam Modlin, Kete Campbell‐Coker, Mark John Edwards, Susannah Pick, L. S. Merritt Millman, Emily Lowery et al. · 2024 · Wellcome Open Research
25. Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey
    Jack Stroud, Charlotte Rice, A Orsini, Marco Schlosser, Justine Lee, William Mandy, Sunjeev K. Kamboj · 2024 · Psychopharmacology
26. Existential feelings as a phenomenological framework for psychedelic therapy
    Floris Benjamin Tijhuis, Sabrina Coninx, Léon C. de Bruin · 2024 · Philosophical Psychology
27. The effects of psychedelic-assisted therapy on illness and death anxiety: A systematic review and meta-analysis
    Aron Amaev, Jianmeng Song, Yasaman Kambari, Edgardo Carmona-Torres, Ali Abdolizadeh, Fumihiko Ueno, Teruki Koizumi, Antonio P. Strafella, Muhammad Ishrat Husain, Ariel Graff‐Guerrero et al. · 2025 · Journal of Psychiatric Research
28. Acute subjective effects of psychedelics in naturalistic group settings prospectively predict longitudinal improvements in trauma symptoms, trait shame, and connectedness among adults with childhood maltreatment histories
    C. J. Healy, Aaron Frazier, Stephen Kirsch, Anna Sanford, Albert Garcia‐Romeu, McWelling Todman, Jeremy Peter Varon, Wendy M. D'Andrea · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
29. Examining the biological causes of eating disorders to inform treatment strategies
    Claire J. Foldi, Kristi R. Griffiths · 2025 · Nature reviews. Neuroscience
30. Esketamine disinhibits brain networks in depression: Evidence from oscillatory and aperiodic activity
    Verina Guirguis, Sanvi Korsapathy, Francesca Pupillo, Robert K. McClure, David Zarzar, Mengsen Zhang, Flavio Frӧhlich, Tobias Schwippel · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
31. Psychedelic medicine: mechanisms, evidence, and translation to practice
    Edward Jacobs, Zarmeen Zahid, Jared T. Hinkle, Sandeep Manel Nayak, David B. Yaden · 2026 · BMJ
32. Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice
    Gabriella Gobbi, Antonio Inserra, Kyle T. Greenway, Michael Lifshitz, Laurence J. Kirmayer · 2022 · Transcultural Psychiatry
33. Psychedelics and the Entropic Brain Beyond the Self
    Hans Van Eyghen · 2023 · International Journal for the Psychology of Religion
34. Psychedelic phenomenology and the role of affect in psychological transformation
    Christopher Kochevar · 2023 · Phenomenology and the Cognitive Sciences
35. Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings
    Christopher R. N. Nicholas, David M. Horton, Julia Malicki, Amelia Baltes, Paul R. Hutson, Randall Brown · 2023 · Psychedelic Medicine
36. Decreased Directed Functional Connectivity in the Psychedelic State
    Lionel Barnett, Suresh D Muthukumaraswamy, Robin Lester Carhart-Harris, Anil K. Seth · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
37. Psilocybin alters brain activity related to sensory and cognitive processing in a time-dependent manner
    Marek Nikolič, Pedro A. M. Mediano, Tom Froese, David Reydellet, Tomáš Páleníček · 2024 · medRxiv
38. The serotonergic psychedelic DOI impairs deviance detection in the auditory cortex
    Max Horrocks, Jennifer L. Mohn, Santiago Jaramillo · 2024 · Journal of Neurophysiology
39. Use of psychedelic treatments in psychiatric clinical practice: an EPA policy paper
    Marianne Destoop, Pavel Mohr, Florence Butlen‐Ducuing, Péter Kéri, Jerzy Samochowiec, Livia De Picker, Andrea Fiorillo, Kim P. C. Kuypers, Geert Dom · 2025 · European Psychiatry
40. A qualitative analysis of the psychedelic mushroom come-up and come-down
    Ari Brouwer, Joshua K. Brown, Earth Erowid, Fire Erowid, Sylvia Thyssen, Charles L. Raison, Robin Lester Carhart-Harris · 2025 · npj Mental Health Research
41. The road to Aha: A recipe for mental breakthroughs.
    Kadi Tulver, Karl Kristjan Kaup, Jaan Aru · 2025 · Cognition
42. Peri-traumatic consumption of classic psychedelics is associated with lower anxiety and post-traumatic responses 3 weeks after exposure
    Einat Karp, Zohar Rubinstein, Rany Abend, Shaul Lev‐Ran, Lia Naor, Mario Mikulincer · 2025 · Journal of Psychopharmacology
43. The Default Mode Network and inner time consciousness
    Georg Northoff, Andrea Buccellato, Bianca Ventura · 2025 · Current Opinion in Behavioral Sciences
44. Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises
    Rebecca Harding, Neomi Singer, Matthew B. Wall, Talma Hendler, David Erritzøe, David Nutt, Robin Lester Carhart-Harris, Leor Roseman · 2025 · Molecular Psychiatry
45. Pharmacological therapies for early and long-term recovery in disorders of consciousness: current knowledge and promising avenues
    Rosalie Girard Pepin, Fatemeh Seyfzadehdarabad, David R. Williamson, Olivia Gosseries, Catherine Duclos · 2025 · Expert Review of Neurotherapeutics
46. Cyberdelics: Virtual reality hallucinations modulate cognitive-affective processes
    Giulia Brizzi, Chiara Pupillo, Clara Rastelli, Antonino Greco, Luca Bernardelli, Anna Flavia Di Natale, Silvia Francesca Maria Pizzoli, Elena Sajno, Fabio Frisone, Daniele Di Lernia et al. · 2025 · Dialogues in Clinical Neuroscience
47. Future Pharmacotherapy for Bipolar Disorders: Emerging Trends and Personalized Approaches
    Giuseppe Marano, Francesco Maria Lisci, Gianluca Boggio, Ester Maria Marzo, Francesca Abate, Greta Sfratta, Gianandrea Traversi, Osvaldo Mazza, Roberto Pola, Gabriele Sani et al. · 2025 · Future Pharmacology
48. Active inference, computational phenomenology, and advanced meditation: Toward the formalization of the experience of meditation
    Hagar Tal, Malcolm Wright, Shawn Prest, Lars Sandved-Smith, Matthew D. Sacchet · 2025 · Neuroscience & Biobehavioral Reviews
49. Intermittent tACS during a visual task impacts neural oscillations and LZW complexity
    Marta Castellano, David Ibáñez-Soria, Eleni Kroupi, Javier Acedo, Michela Campolo, Xenia Martinez, Aureli Soria‐Frisch, Josep Valls-Solé, Ajay Verma, Giulio Ruffini · 2020 · Experimental Brain Research
50. EMBARK Psychedelic Therapy for Depression
    Bill Brennan, Alex Belser · 2024
51. Epigenetic drugs and psychedelics as emerging therapies for alcohol use disorder: insights from preclinical studies
    Fahd François Hilal, Jérôme Jeanblanc, Chloé Deschamps, Mickaël Naassïla, Olivier Pierrefiche, Sami Ben Hamida · 2024 · Journal of Neural Transmission
52. Structured Dynamics in the Algorithmic Agent
    Giulio Ruffini, Francesca Castaldo, Jakub Vohryzek · 2025 · Entropy
53. The neuroscience of breathlessness
    Anton Pick, Shaene Gnanarajah, Emily Fraser, Kyle T.S. Pattinson · 2022 · European Respiratory Society eBooks
54. Primary states of consciousness: A review of historical and contemporary developments
    Félix Schoeller · 2023 · Consciousness and Cognition
55. How Level is the 'Cognitive Playing Field'?
    Joshua Michael Martin, Philipp Sterzer · 2022 · Philosophy and the Mind Sciences
56. Aesthetic chills foster self-acceptance and emotional breakthrough in depression
    Félix Schoeller, Abhinandan Jain, Vladimir Adrien, Pattie Maes · 2022 · PsyArXiv (OSF Preprints)
57. The computational unconscious: Adaptive narrative control, psychopathology, and subjective well-being
    George Deane, Jonas Mago, Aikaterini Fotopoulou, Matthew D. Sacchet, Robin Lester Carhart-Harris, Lars Sandved-Smith · 2024 · PsyArXiv (OSF Preprints)
58. Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT
    Jakub Vohryzek, Andrea I. Luppi, Selen Atasoy, Gustavo Deco, Christopher Timmermann, Robin Lester Carhart-Harris, Morten L. Kringelbach · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
59. Complex slow waves radically reorganise human brain dynamics under 5-MeO-DMT
    George Blackburne, Rosalind G. McAlpine, Marco S. Fabus, Alberto Liardi, Sunjeev K. Kamboj, Pedro A. M. Mediano, Jeremy I Skipper · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
60. Perceived Impact of Psychedelics on Sexual, Gender, and Intimate Relationship Dynamics: A Mixed-Methods Investigation
    Daniel J. Kruger, Eirini K. Argyri, Justin K. Mogilski, Moss Herberholz, Julie Barron, Jacob S. Aday, Kevin F. Boehnke · 2025 · The Journal of Sex Research
61. Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis
    Simon Reiche, Tim Hirschfeld, Anna Gröticke, Marie Traub, Nicklas Jakob Hafiz, Rico Haas, Lara Sedlaczek, Linda Ortlieb, Georg Leistenschneider, Lukas Andreas Basedow et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
62. Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences
    Federico Seragnoli, Fabienne Picard, Gabriel Thorens, Albert Buchard, M Geyer, Angela Abatista, Polina Ponomarenko, Cyril Petignat, Marco Riccardi, Maëlle Dreifuss Bisson et al. · 2025 · Cognitive Therapy and Research
63. Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies
    William Roseby, Hannes Kettner, Leor Roseman, Meg J. Spriggs, Taylor Lyons, Joe Peill, Bruna Giribaldi, David Erritzøe, David John Nutt, Robin Lester Carhart-Harris · 2025 · Frontiers in Psychology
64. Exploring the therapeutic potential of psychedelics in treating substance use disorders
    Y Li, Hongyuan Li, Hongshuang Wang, Xiaohui Wang · 2025 · Molecular Psychiatry
65. EEG entropy modulation as a biomarker of emotion regulation and resilience
    William Tanner Creel, Richard E. Hartman · 2025 · IBRO Neuroscience Reports
66. The Double-Slit Experiment Is Already Happening in the Brain
    Jaba Tkemaladze · 2026 · Longevity Horizon
67. The Psychology of Mysticism
    Zhuo Job Chen · 2026 · Cambridge University Press eBooks
68. A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive–compulsive disorder
    Francisco A. Moreno, Katja Ehrmann, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze, John J. B. Allen · 2026 · Journal of Psychopharmacology
69. Seeing oneself through the eyes of another: A look at psychedelic insight
    Lawrence G. Fischman · 2022 · Neuropsychoanalysis
70. Puzzled by dysfunctional breathing disorder(s)? Consider the Bayesian brain hypothesis!
    Claudine Peiffer · 2023 · Frontiers in Neuroscience
71. Playfulness and the meaningful life: an active inference perspective
    Julian D Kiverstein, Mark M. Miller · 2023 · Neuroscience of Consciousness
72. Psychedelic-assisted therapy for people with gambling disorder?
    Pedro Romero, Andrea Czakó, Wim van den Brink, Zsolt Demetrovics · 2024 · Journal of Behavioral Addictions
73. Cyberdelics: Context engineering psychedelics for altered traits
    Carl Hayden Smith, Melissa Warner · 2022 · Electronic workshops in computing
74. Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review
    Sascha B. Thal, Michelle Wieberneit, Jason M. Sharbanee, Petra Skeffington, Raimondo Bruno, Tobias Wenge, Stephen Jason Bright · 2023 · Journal of Humanistic Psychology
75. Suicide prevention and ketamine: insights from computational modeling
    Charlton, Colleen E., Karvelis, Povilas, McIntyre, Roger S., Diaconescu, Andreea O. · 2023 · Frontiers in Psychiatry
76. Naturalism and the hard problem of mysticism in psychedelic science
    Jussi Jylkkä · 2024 · Frontiers in Psychology
77. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets
    Teresa Reynolds de Sousa, João Rema, Sergio Eduardo de Carvalho Machado, Filipa Novais · 2021 · Current Topics in Medicinal Chemistry
78. The meditative brain: State and trait changes in harmonic complexity for long-term mindfulness meditators
    Selen Atasoy, Anira Escrichs, Eloise A. Stark, Kendra G. M. Terry, Estela Càmara, Ana Sanjuán, Shamil Chandaria, Gustavo Deco, Morten L. Kringelbach · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
79. Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysis
    Ching, T. H. W., Stahnke, B., Shnayder, S., Agin-Liebes, G., Adams, T. G., Amoroso, L., Baiz, O., Belser, A., Bohner, C., Burke, M. et al. · 2025 · Frontiers in Psychiatry
80. Psychoanalytically informed MDMA-assisted therapy for pathological narcissism: a novel theoretical approach
    Albert, Alexa E., Back, Anthony L. · 2025 · Frontiers in Psychiatry
81. Modern perspectives on psychoses: dissociation, automatism, and temporality across exogenous and endogenous dimensions
    Ricci, Valerio, Ciavarella, Maria Celeste, Marrangone, Carlotta, Messas, Guilherme, Maina, Giuseppe, Martinotti, Giovanni · 2025 · Frontiers in Psychiatry
82. Does Mystical Experience Give Access to Reality?
    Marshall, Paul · 2022 · Religions
83. Psychedelic Mysticism and Christian Spirituality: From Science to Love
    Ron Cole‐Turner · 2024 · Religions
84. The effects of psilocybin on cognition and emotional processing in healthy adults and adults with depression: a systematic literature review
    Laura Ramos, Selene Vicente · 2024 · Journal of Clinical and Experimental Neuropsychology
85. Moderating factors in psilocybin-assisted treatment affecting mood and personality: A naturalistic, open-label investigation
    Mona Irrmischer, Drew J. Puxty, Barış Onur Yıldırım, J.B. Deijen, Hessel Engelbregt · 2025 · Psychopharmacology
86. Naturalistic psychedelic experiences and gender-based self-acceptance in transgender and gender-expansive people
    Skylar J. Gaughan, Angie R. Wootton, Daphne Krantz, Alan K. Davis, Jennifer Elyse James, Rocco Rinaldi-Rose, Rafael Lancelotta, Jae M. Sevelius · 2025 · International Journal of Transgender Health
87. Leveraging family and caregiver support in psychedelic-assisted therapy: considerations for the treatment of adolescents
    Sarah Forsberg, Amanda E. Downey, Lindsey D. Bruett, Lisa Hail, Gisele Fernandes‐Osterhold, Josh D. Woolley, Adèle Lafrance, Marissa Raymond‐Flesch · 2025 · Child and Adolescent Psychiatry and Mental Health
88. What fMRI studies say about the nature of the psychedelic effect: a scoping review
    Michal Beneš, Tomáš Páleníček, Jiřı́ Horáček · 2025 · Frontiers in Neuroscience
89. Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin
    Ross J. Purple, Rahul Gupta, Christopher W. Thomas, Caroline T. Golden, Nicola Palomero‐Gallagher, Robin Lester Carhart-Harris, Seán Froudist‐Walsh, Matthew W. Jones · 2025 · Molecular Psychiatry
90. Emerging Interventions in Behavioral Addictions: A Narrative Review of Psychedelics and Neuromodulation
    Krista Ulisse, Jehad Albitar, Jourdan T. Aromin, James H. Berry · 2025 · Brain Sciences
91. Ze and Relational QM
    Jaba Tkemaladze · 2026 · Longevity Horizon
92. Quantum Behavior as a Consequence of Ze Systems
    Jaba Tkemaladze · 2026 · Longevity Horizon
93. Psychedelic-assisted Psychotherapy in 3-D: Acceptance, Connectedness, and Defensiveness
    Lawrence G. Fischman · 2023 · Neuropsychoanalysis
94. Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.
    David Wyndham Lawrence · 2023 · PubMed Central
95. Religion and the brain: Jordan Grafman's contributions to religion and brain research and the special case of religious language
    Patrick McNamara · 2023 · Cortex
96. Grief as self-model updating
    José M. Araya · 2023 · Phenomenology and the Cognitive Sciences
97. Significant Psychedelic Experiences Evaluated for Mystical Characteristics Associated with Cannabis Use Reduction and Psychological Flexibility Improvement: A Naturalistic Cross-Sectional Retrospective Survey
    Bruno Roméo, Ewen Kervadec, Baptiste Fauvel, Lana Strika-Bruneau, Ammar Amirouche, Vincent Verroust, Pascale Piolino, Amine Benyamina · 2024 · Journal of Psychoactive Drugs
98. The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication
    Elena Koning, Marco Solmi, Elisa Macedo Brietzke · 2024 · Trends in Psychiatry and Psychotherapy
99. Psychedelics and psychoanalysis: The journey from talking cure to transformation
    Jonathan Lichtenstein, Nicholas R. Hoeh · 2024 · Journal of Psychedelic Studies
100. Meditation expertise influences response bias and prestimulus alpha activity in the somatosensory signal detection task
     Maik Mylius, Simón Guendelman, Fivos Iliopoulos, Vittorio Gallese, Laura Kaltwasser · 2024 · Psychophysiology